These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Are statin effects mediated through, or in spite of, their cholesterol-lowering action? Mascitelli L; Pezzetta F; Goldstein MR Angiology; 2009; 60(2):262-3. PubMed ID: 19141486 [No Abstract] [Full Text] [Related]
3. [Statins--the panacea of the turn of the century?]. Lubiszewska B; Ruzyłło W Pol Arch Med Wewn; 2004 May; 111(5):617-24. PubMed ID: 15508815 [No Abstract] [Full Text] [Related]
4. Primary prevention of cardiovascular disease with statins: cautionary notes. Goldstein MR; Mascitelli L; Pezzetta F QJM; 2009 Nov; 102(11):817-20. PubMed ID: 19620217 [No Abstract] [Full Text] [Related]
5. Genetic determinants of response to statins. Peters BJ; Klungel OH; de Boer A; Maitland-van der Zee AH Expert Rev Cardiovasc Ther; 2009 Aug; 7(8):977-83. PubMed ID: 19673675 [TBL] [Abstract][Full Text] [Related]
6. Guidelines target many women for statins. Harv Womens Health Watch; 2002 Apr; 9(8):1-2. PubMed ID: 11959535 [No Abstract] [Full Text] [Related]
7. Statins' role in prevention. Do statins have a role in primary prevention of cardiovascular events? Can Fam Physician; 2004 Aug; 50():1091. PubMed ID: 15455806 [No Abstract] [Full Text] [Related]
8. Prescribing statins: the real issues. Hamilton-Craig IR Med J Aust; 2014 May; 200(8):440-1. PubMed ID: 24794593 [No Abstract] [Full Text] [Related]
9. Statins as cardioprotective agents. Piskur JR; Stone NJ Am J Manag Care; 2002 Jun; 8(9 Suppl):25-9. PubMed ID: 12099325 [No Abstract] [Full Text] [Related]
10. Study stirs debate about statin use in those without high cholesterol. Mayo Clin Womens Healthsource; 2009 Apr; 13(4):3. PubMed ID: 19255535 [No Abstract] [Full Text] [Related]
11. [Lowering cholesterol: how low is low enough?]. Czuriga I; Edes I Orv Hetil; 2006 Jul; 147(29):1349-56. PubMed ID: 16941825 [TBL] [Abstract][Full Text] [Related]
13. A focus on cardiovascular risk modification: clinical significance and implementation of the 2013 ACC/AHA cholesterol guidelines. Kelly SC; Gonzalo R; Petrasko M S D Med; 2014 Aug; 67(8):320-3. PubMed ID: 25163226 [No Abstract] [Full Text] [Related]
15. [HMG-CoA reductase inhibitors in prevention of cardiovascular diseases: new mechanisms, aspects and trials]. Wojakowski W; Gmiński J Przegl Lek; 2000; 57(5):291-5. PubMed ID: 11057120 [TBL] [Abstract][Full Text] [Related]
16. Basic science review: Statin therapy--Part I: The pleiotropic effects of statins in cardiovascular disease. Sadowitz B; Maier KG; Gahtan V Vasc Endovascular Surg; 2010 May; 44(4):241-51. PubMed ID: 20403949 [TBL] [Abstract][Full Text] [Related]
17. Statins in women for primary prevention--is there evidence to back up their use?? Fenton A; Panay N Climacteric; 2010 Oct; 13(5):403-4. PubMed ID: 20738236 [No Abstract] [Full Text] [Related]
19. Is it appropriate to make statins available over the counter? The argument against the appropriateness of over-the-counter statins. Barter PJ; Rye KA Circulation; 2006 Sep; 114(12):1315-20; discussion 1320. PubMed ID: 16982953 [No Abstract] [Full Text] [Related]